- Report: Biotech sector raised $1.3B in Q4 venture funding
Venture capital investments in the biotechnology industry dropped 6% year-to-year to almost $1.3 billion during the fourth quarter of 2012, but the number of deals grew by 8% to 135 during the period, according to the quarterly MoneyTree Report. For the entire year, biotech firms secured almost $4.1 billion, a decline of 15% from 2011, while the number of deals was fairly steady at 466. Genetic Engineering & Biotechnology News (1/18)       | Onyx Public Offering Will Beef Up Kyprolis Marketing Push | | Onyx Pharmaceuticals Inc.'s new multiple myeloma drug Kyprolis (cartilzomib) will get a $358.6 million boost following a new public offering of stock from the south San Francisco-based company. The offering of 4.4 million shares will fund clinical development. Find out the details. |  |
- 6 states consider bills regarding biosimilars
Six states could consider bills involving the interchangability of biosimilars and brand-name biologics. In Virginia, a legislative panel endorsed a bill that would authorize pharmacists to dispense biosimilars that the FDA considers interchangeable, while a Pennsylvania lawmaker says rules on generics aren't applicable to biosimilars and new legislation is needed. In 2012, changes were proposed to Illinois' Pharmacy Practice Act, while Indiana, North Dakota and Texas also are considering bills. Pharmalot.com/Pharma Blog (1/18) - Study to test solanezumab's potential in preventing Alzheimer's
Dr. Reisa Sperling, director of the Alzheimer's disease center at Brigham and Women's Hospital in Boston, will be heading a study that will test an experimental drug from Eli Lilly & Co. called solanezumab. The study, to include 1,000 people with plaque buildup but no signs of dementia, will test whether the drug can prevent the development of Alzheimer's when administered before symptoms manifest. Researchers are also paying close attention to whether the drug can at least hinder the speed of cognitive degeneration. The Washington Times/The Associated Press (1/18)  | Dell has your IT wish list covered.
Desktops, laptops and accessories. Save up to 35% on the latest technology for your medical practice. The lightest and thinnest of the Latitude E-Family, the Latitude™ E6230 delivers business-class control and a professional docking ecosystem. Shop Now. |
  | Manage your business with the help of a dedicated partner:
• Control expenses by setting a credit limit for each employee card
• Personal Business Assistant 24-hour Concierge service can help with dining or travel arrangements, or help to find a local marketing firm
• Stay protected with benefits like Retail Purchase Protection and Emergency Assistance*
*Learn more. |
  | Food & Agriculture |  |  | | - Dow now looks to 2014 season for Enlist corn
Dow AgroSciences said it is awaiting U.S. regulatory clearance for its Enlist herbicide-resistant corn and expects to launch the product next year. Dow had previously aimed for sales for this year's planting season. Reuters (1/18) | Hot Topics | | | | Top five news stories selected by BIO SmartBrief readers in the past week. - Results based on number of times each story was clicked by readers.
| Industrial & Environmental | | | | - Researchers see biofuel potential in artificial photosynthesis
British researchers at the University of East Anglia and their colleagues are developing technology to mimic photosynthesis in a bid to produce hydrogen for biofuel and other applications. "We imagine that our photocatalysts will prove versatile and that with slight modification they will be able to harness solar energy for the manufacture of carbon-based fuels, drugs and fine chemicals," said Julea Butt, the lead researcher. Reuters (1/21)  | |  | | The Buzz(CORPORATE ANNOUNCEMENTS)
| |  | |  |
| News from BIO | | | | - Ship with FedEx
FedEx is now offering member companies discounts of up to 35% off select FedEx services, both U.S. and international services. The BIO program with FedEx is one of the many cost-savings programs offered by BIO through its Business Solutions program. There is no charge for BIO member companies to participate in any of the BIO Business Solutions programs -- it is a benefit of membership. Learn more about the BIO and FedEx program.
| SmartQuote | | | |  | Give me six hours to chop down a tree and I will spend the first four sharpening the axe."
--Abraham Lincoln,
16th U.S. president  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Friday, January 18, 2013
- Thursday, January 17, 2013
- Wednesday, January 16, 2013
- Tuesday, January 15, 2013
- Monday, January 14, 2013
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2013 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment